Safety and usefulness of Enoxaparin versus unfractionated heparin in patients with ST elevation myocardial infarctio
Phase 3
- Conditions
- Ischaemic heart diseases.Acute myocardial infarction
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Inclusion Criteria: Age range 18 to 75 years old, onset of symptoms of acute myocardial infarction within 12 hrs before randomization, ST-segment elevation of 0.1 mV or more in two or more limbs leads or at least 0.2 mV in two or more precordial leads.
Exclusion Criteria
Contraindications to streptokinase, cardiogenic shock, receiving glycoprotein IIb/IIIa antagonists or oral anticoagulants within the prior days or therapeutic dose of heparin or low molecular-weight heparin within the previous hours, need for anticoagulant therapy and also any other disease that resulted in increasing risk
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ST-segment resolution. Timepoint: 90 minutes after intervention. Method of measurement: ECG.;Ejection Fraction. Timepoint: during 5-10th day of admission. Method of measurement: Angiography.;Thombolysis in Myocardial Infarction (TIMI) flow grade 3 (patency). Timepoint: during 5-10th day of admission. Method of measurement: Through angiography.
- Secondary Outcome Measures
Name Time Method